Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Ertapenem
2. Ertapenem Sodium
3. Invanoz
1. Ertapenem Sodium
2. Ertapenem Monosodium
3. Ertapenem Sodium [usan]
4. Ertapenem Monosodium (90per Cent)
5. 153773-82-1
6. Mk 0826
7. Sodium;(4r,5s,6s)-3-[(3s,5s)-5-[(3-carboxylatophenyl)carbamoyl]pyrrolidin-1-ium-3-yl]sulfanyl-6-[(1r)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
8. 2t90ke67l0
9. Mk 826
10. Unii-2t90ke67l0
11. L 749345
12. 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic Acid, 3-(((3s,5s)-5-(((3-carboxyphenyl)amino)carbonyl)-3-pyrrolidinyl)thio)-6-((1r)-1-hydroxyethyl)-4-methyl-7-oxo-, Monosodium Salt, (4r,5s,6s)-
13. 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic Acid, 3-((5-(((3-carboxyphenyl)amino)carbonyl)-3-pyrrolidinyl)thio)-6-((1r)-1-hydroxyethyl)-4-methyl-7-oxo-, Monosodium Salt, (4r-(3(3s*,5s*),4alpha,5beta,6beta(r*)))-
14. Sodium (4r,5s,6s)-3-({(3s,5s)-5-[(3-carboxylatophenyl)carbamoyl]pyrrolidinium-3-yl}sulfanyl)-6-[(1r)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
15. Sodium (4r,5s,6s)-3-({(3s,5s)-5-[(m-carboxylatophenyl)carbamoyl]pyrrolidinium-3-yl}sulfanyl)-6-[(1r)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
16. Sodium (4r,5s,6s)-3-({(3s,5s)-5-[(m-carboxyphenyl)carbamoyl]-3-pyrrolidinyl}thio)-6-[(1r)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
Molecular Weight | 497.5 g/mol |
---|---|
Molecular Formula | C22H24N3NaO7S |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 5 |
Exact Mass | 497.12326557 g/mol |
Monoisotopic Mass | 497.12326557 g/mol |
Topological Polar Surface Area | 192 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 882 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
* Treatment:
Treatment of the following infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required:
- intra-abdominal infections;
- community-acquired pneumonia;
- acute gynaecological infections;
- diabetic foot infections of the skin and soft tissue.
* Prevention:
Invanz is indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery.
Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J01DH03
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
48
PharmaCompass offers a list of Ertapenem API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ertapenem manufacturer or Ertapenem supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ertapenem manufacturer or Ertapenem supplier.
PharmaCompass also assists you with knowing the Ertapenem API Price utilized in the formulation of products. Ertapenem API Price is not always fixed or binding as the Ertapenem Price is obtained through a variety of data sources. The Ertapenem Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A MSD brand of ertapenem manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of MSD brand of ertapenem, including repackagers and relabelers. The FDA regulates MSD brand of ertapenem manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. MSD brand of ertapenem API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of MSD brand of ertapenem manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A MSD brand of ertapenem supplier is an individual or a company that provides MSD brand of ertapenem active pharmaceutical ingredient (API) or MSD brand of ertapenem finished formulations upon request. The MSD brand of ertapenem suppliers may include MSD brand of ertapenem API manufacturers, exporters, distributors and traders.
click here to find a list of MSD brand of ertapenem suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A MSD brand of ertapenem DMF (Drug Master File) is a document detailing the whole manufacturing process of MSD brand of ertapenem active pharmaceutical ingredient (API) in detail. Different forms of MSD brand of ertapenem DMFs exist exist since differing nations have different regulations, such as MSD brand of ertapenem USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A MSD brand of ertapenem DMF submitted to regulatory agencies in the US is known as a USDMF. MSD brand of ertapenem USDMF includes data on MSD brand of ertapenem's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The MSD brand of ertapenem USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of MSD brand of ertapenem suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a MSD brand of ertapenem Drug Master File in Korea (MSD brand of ertapenem KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of MSD brand of ertapenem. The MFDS reviews the MSD brand of ertapenem KDMF as part of the drug registration process and uses the information provided in the MSD brand of ertapenem KDMF to evaluate the safety and efficacy of the drug.
After submitting a MSD brand of ertapenem KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their MSD brand of ertapenem API can apply through the Korea Drug Master File (KDMF).
click here to find a list of MSD brand of ertapenem suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing MSD brand of ertapenem as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for MSD brand of ertapenem API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture MSD brand of ertapenem as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain MSD brand of ertapenem and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a MSD brand of ertapenem NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of MSD brand of ertapenem suppliers with NDC on PharmaCompass.
MSD brand of ertapenem Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of MSD brand of ertapenem GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right MSD brand of ertapenem GMP manufacturer or MSD brand of ertapenem GMP API supplier for your needs.
A MSD brand of ertapenem CoA (Certificate of Analysis) is a formal document that attests to MSD brand of ertapenem's compliance with MSD brand of ertapenem specifications and serves as a tool for batch-level quality control.
MSD brand of ertapenem CoA mostly includes findings from lab analyses of a specific batch. For each MSD brand of ertapenem CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
MSD brand of ertapenem may be tested according to a variety of international standards, such as European Pharmacopoeia (MSD brand of ertapenem EP), MSD brand of ertapenem JP (Japanese Pharmacopeia) and the US Pharmacopoeia (MSD brand of ertapenem USP).